Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
CNS Drugs
.
2019 Apr;33(4):397.
doi: 10.1007/s40263-019-00617-3.
Authors
Lesley Taylor
1
,
Barry Gidal
2
,
Graham Blakey
3
,
Bola Tayo
1
,
Gilmour Morrison
4
Affiliations
1
GW Research Ltd, Cambridge, UK.
2
University of Wisconsin School of Pharmacy, Madison, WI, USA.
3
Consult2deliver Ltd, Nottingham, UK.
4
GW Research Ltd, Cambridge, UK. GMorrison@gwpharm.com.
PMID:
30830575
PMCID:
PMC6828038
DOI:
10.1007/s40263-019-00617-3
Abstract
Page 1065, Discussion, Single and Multiple Dose CBD PK, column 2 - the equation that read.
Publication types
Published Erratum